Reuters logo
BRIEF-Tianjin Zhongxin Pharmaceutical Group ‍signed investment product agreement with China Bohai Bank
August 24, 2017 / 10:13 AM / 4 months ago

BRIEF-Tianjin Zhongxin Pharmaceutical Group ‍signed investment product agreement with China Bohai Bank

Aug 24 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd-

* Signed investment product agreement with China Bohai Bank to invest rmb200 million into capital-protected investment product​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below